Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
Human Oncostatin M Protein expressed in Escherichia coli (E. coli) - ABIN2666535
Beigel, Friedrich, Probst, Sotlar, Göke, Diegelmann, Brand: Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members. in PLoS ONE 2014
Show all 7 references for ABIN2666535
Human Oncostatin M Protein expressed in Escherichia coli (E. coli) - ABIN2667567
Chen, Benveniste: Oncostatin M: a pleiotropic cytokine in the central nervous system. in Cytokine & growth factor reviews 2004
Show all 5 references for ABIN2667567
Human Oncostatin M Protein expressed in HEK-293 Cells - ABIN2181568
Tanaka, Miyajima: Oncostatin M, a multifunctional cytokine. in Reviews of physiology, biochemistry and pharmacology 2003
Show all 3 references for ABIN2181568
Human Oncostatin M Protein expressed in HEK293 - ABIN2039658
Yin, Chain: Suppression of lymphokine production in anti-minor histocompatibility antigen responses. in Cytokine 1991
Show all 3 references for ABIN2039658
Human Oncostatin M Protein expressed in Escherichia coli (E. coli) - ABIN413690
Sen, Che, Rajamani, Zerboni, Sung, Ptacek, Arvin: Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. in Proceedings of the National Academy of Sciences of the United States of America 2012
Show all 2 references for ABIN413690
Human Oncostatin M Protein expressed in Escherichia coli (E. coli) - ABIN667495
Nair, DeVico, Nakamura, Copeland, Chen, Patel, ONeil, Oroszlan, Gallo, Sarngadharan: Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. in Science (New York, N.Y.) 1992
Show all 2 references for ABIN667495
Study showed that in atrial fibrillation (AF) with thrombus, the atrial tissue infiltration of M1 macrophages increased significantly; the OSM expression was also found to increase simultaneously; downstream tissue factor (show F3 Proteins) (TF) increased and tissue factor (show F3 Proteins) pathway inhibitors (TFPI (show TFPI Proteins))decreased, leading to an imbalance between TF and TFPI (show TFPI Proteins) eventually. OSM might be related to thrombosis in patients with AF mediated by TF and TFPI (show TFPI Proteins)
a novel STAT3 (show STAT3 Proteins)/SMAD3 (show SMAD3 Proteins)-signaling axis is required for OSM-mediated senescence.
This result demonstrates that HPV16 oncoproteins upregulate oncostatin M and play an important role to promote oral squamous cell carcinoma development
The identification of the OSM inflammatory pathway as an important mediator of epithelial mesenchymal transition in triple-negative breast cancer (TNBC) may provide a novel potential opportunity to improve therapeutic strategies.
Nucleolin stabilizes oncostatin-M mRNA by binding to a GC-rich element in its 3'UTR.
Oncostatin M and interleukin-31 (show IL31 Proteins): Cytokines, receptors, signal transduction and physiology.
Oncostatin M can regulate airway smooth muscle responses alone or in synergy with IL-17A (show IL17A Proteins).
we demonstrated that recombinant human OSM (rhOSM) promoted tumor angiogenesis in EC cell lines by activating STAT3 (signal transducer and activator of transcription 3 (show STAT3 Proteins)) and enhanced both cell migration and cell inva
OSM expression in osteoblasts increases in response to Osteopontin (show SPP1 Proteins)-induced inflammation in vitro.
Data suggest that OSM promotes osteoblastic differentiation of vascular smooth muscle cells through JAK3 (show JAK3 Proteins)/STAT3 (show STAT3 Proteins) pathway and may contribute to the development of atherosclerotic calcification.
these results support the proinflammatory role of OSM when it is overexpressed in the skin. However, OSM expression was not required in the murine model of psoriasis induced by topical application of imiquimod, as demonstrated by the inflammatory phenotype of OSM-deficient mice or wild-type mice treated with anti-OSM antibodies.
OSM (mOSM) signals mainly via an OSM receptor (OSMR (show OSMR Proteins))-gp130 (show LRPPRC Proteins) heterodimer and binds with only very low affinity to mLIFR.
Loss of Oncostatin M Signaling in Adipocytes Induces Insulin (show INS Proteins) Resistance and Adipose Tissue Inflammation in Vivo.
mechanism of OSM-induced cardiomyocyte dedifferentiation is associated with B-Raf (show SNRPE Proteins)/Mek (show MDK Proteins)/Erk (show EPHB2 Proteins) signaling pathway through the OSM receptor Obeta
OSM plays multiple critical roles in the maintenance and development of the hematopoietic microenvironment in the bone marrow at a steady state as well as after injury.
OSM treatment preserved cardiac function, inhibited apoptosis and fibrosis, and stimulated angiogenesis via upregulating VEGF (show VEGFA Proteins) and bFGF (show FGF2 Proteins) in infarct border zone of ischemic myocardium, indicating that OSM could be a novel therapeutic target for MI.
The mechanism of Oncostatin M on cardiac ischemia/reperfusion injury is partly mediated by the Notch3 (show NOTCH3 Proteins)/Akt (show AKT1 Proteins) pathway.
OSM-induced osteogenesis and upregulation of osteogenic gene products require activity of PKCdelta (show PKCd Proteins).
The Notch (show NOTCH1 Proteins) signaling pathway was found to be one of the signaling pathways that inhibit OSM-induced MC3T3-E1 cell proliferation and differentiation.
Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes.
Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. This gene encodes a growth regulator which inhibits the proliferation of a number of tumor cell lines. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells.